Dr. Martens – Q3 ‘in line with full year guidance’, but that’s not really an achievement!…
Footwear brand company Dr. Martens (DOCS) has issued its third quarter, to end-December, trading statement with CEO Kenny Wilson commencing that, “Our Q3 performance is in line with the updated full year guidance provided in November” and concluding “we are taking action to continue to grow our iconic brand and invest in our business. We remain confident in our product pipeline for AW24 and beyond”. What of a current around 81p share price in response to the announcement?


